logo
15:43 Dec 05

Hester Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1653.40
+9.00 (+0.55%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hester Biosciences Ltd. Financials

Hester Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1653.40
+9.00 (+0.55%)
15:43 Dec 05
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

7

Weakness

6

Opportunity

1

Threats

0

8.74 %

ROE %

4.20 %

ROA %

51.54

EPS

369.41

BVPS

8.83 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
235.01 266.09 304.55 311.1 312.93
Operating Expenses +
175.03 215.48 250.89 250.06 246.74
Raw Material
73.27 82.74 87.13 81.55 78.65
Increase Decrease in Cost
-10.56 -5.25 8.74 6.78 8.71
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
45.33 56.02 64.13 62.42 61.71
Miscellaneous Expenses
92.23 141.47 156.53 134.51 97.67
Operating Profit
59.98 50.61 53.66 61.04 66.19
Other Income
13.74 15.15 10.64 3.92 5.02
Depreciation
16.58 20.7 17.17 16.8 16.85
Interest
4.06 9.32 19.78 12.7 9.51
Profit before tax and exceptio..
53.08 35.74 27.34 35.47 44.85
Exceptional Items
0 0 0 0 0
PBT
53.08 35.74 27.34 35.47 44.85
Provision for Taxation
14.02 12.12 10.79 10.74 10.53
Net Profit
39.06 23.63 16.56 24.73 34.35
NET Profit after MI
39.48 26.63 18.89 27.49 37.59
EPS
46.41 32.96 24.88 33.89 45.42
Operating Profit Margin (%)
25.52 19.02 17.62 19.62 21.15
Net Profit Margin (%)
16.8 10.01 6.2 8.84 12.01

Hester Biosciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 53.70 53.70 53.70 53.70 53.70 53.70
FII 0.50 0.50 0.90 0.60 0.60 0.50
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 45.80 45.80 45.40 45.70 45.70 45.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: